AI brief of an SEC Form 8-K · Gabelli Healthcare & WellnessRx Trust (GRX)

Gabelli Healthcare & WellnessRx Trust: Portfolio manager Mario Gabelli out after medical incident

Neutral Impact 4 of 5 leadership Written later

The Trust disclosed that Mario J. Gabelli, its trustee and chief investment officer, was admitted to hospital for observation and testing after a medical incident on March 19, 2026. The filing says his condition is improving but his return timeline is unknown, and Kevin V. Dreyer and Christopher J. Marangi now lead the Fund's portfolio management team in his absence.

Key points

  • Mario J. Gabelli was hospitalized for observation and testing after a medical incident on March 19, 2026; his return date is not yet known.
  • On March 22, 2026, GAMCO implemented a succession plan and named Christopher J. Marangi its President.
  • Kevin V. Dreyer and Christopher J. Marangi lead the Fund's portfolio management team during Mr. Gabelli's absence.
  • Day-to-day operations of GAMCO continue under co-CEO Douglas R. Jamieson and Christopher J. Marangi.

The filing

CompanyGabelli Healthcare & WellnessRx Trust (GRX)
Form8-K, current report
Filed with the SECMay 7, 2026, 5:07 PM ET
Accession number0001829126-26-004785

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.